Filter by: patients
What is montelukast?

Montelukast is used for prophylaxis and chronic treatment of asthma; relief of symptoms of seasonal allergic rhinitis and perennial allergic rhinitis; prevention of exercise-induced bronchospasm. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Asthma 139 36 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Allergies 131 21 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 43 9 Efficacy_major Efficacy_moderate Efficacy_cant_tell
Seasonal Allergy 30 2 Efficacy_major Efficacy_moderate
Perennial Allergy 30 3 Efficacy_major Efficacy_cant_tell
Asthma 27 6 Efficacy_major Efficacy_moderate Efficacy_cant_tell

See all 368 patients currently taking montelukast

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
3
Moderate
4
Mild
7
None
57

Reported Dosages

Frequently reported dosages based on patients currently taking montelukast. See all 15 dosages

  daily 4 mg daily 5 mg daily 8 mg daily 10 other daily 10 mg daily 10 mcg daily 20 mg daily 25 mg daily 30 daily
  13 Number of Patients: 13 17 Number of Patients: 17 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 325 Number of Patients: 325 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking montelukast (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 18   Expense: 25%
Other 16   Other: 23%
Did not seem to work 13   Did not seem to work: 18%
Doctor's advice 11   Doctor's advice: 15%
Side effects too severe 9   Side effects too severe: 13%
Course of treatment ended 8   Course of treatment ended: 11%
Change in health plan coverage 6   Change in health plan coverage: 8%
Personal research 4   Personal research: 6%
Not indicated 1   Not indicated: 1%

See all 69 patients who’ve stopped taking montelukast

Currently Taking montelukast

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking montelukast

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of montelukast

Always
59 83%
Usually
11 15%
Sometimes
0 0%
Never
1 1%

Burden

Difficulty being on treatment

Burden of montelukast

Very
1 1%
Somewhat
3 4%
A little
5 7%
Not at all
62 87%

Cost

Paid out of pocket

Cost of montelukast

$200+
0 0%
$100-199
1 3%
$50-99
6 15%
$25-49
12 31%
< $25
20 51%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 10, 2012.